A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is associated with increased cardiovascular morbidity and mortality. Elevated arterial stiffness, measured by aortic pulse wave velocity (aPWV), is a cardiovascular risk surrogate and is potentially modifiable by inhaled corticosteroid/long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Surya P, Dransfield, Mark T, Cockcroft, John R, Wang-Jairaj, Jie, Midwinter, Dawn A, Rubin, David B, Scott-Wilson, Catherine A, Crim, Courtney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261599/
https://www.ncbi.nlm.nih.gov/pubmed/28176907
http://dx.doi.org/10.2147/COPD.S117373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261599/
https://www.ncbi.nlm.nih.gov/pubmed/28176907
http://dx.doi.org/10.2147/COPD.S117373

Ejemplares similares